Net sales (including other operating income) of P I Industries has increased 0.17% to Rs 1900.8 crore. Sales of Agro Chemicals segment has gone up 3.84% to Rs 1,838.10 crore (accounting for 96.65% of total sales). Sales of Pharma segment has gone down 49.96% to Rs 63.70 crore (accounting for 3.35% of total sales). Profit before interest, tax and other unallocable items (PBIT) has slumped 8.58% to Rs 480.70 crore. PBIT of Agro Chemicals segment fell 1.38% to Rs 536.60 crore (accounting for 111.63% of total PBIT). PBIT of Pharma segment fell 205.46% to Rs -55.90 crore (accounting for -11.63% of total PBIT). PBIT margin of Agro Chemicals segment fell from 30.74% to 29.19%. PBIT margin of Pharma segment fell from negative 14.38% to negative 87.76%. Overall PBIT margin fell from 27.71% to 25.28%. Operating profit margin has declined from 29.18% to 26.94%, leading to 7.51% decline in operating profit to Rs 512.00 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 42.42% to 42.96%. Purchase of finished goods cost rose from 2.31% to 2.38%. Employee cost increased from 10.10% to 10.42%. Other expenses rose from 15.07% to 16.30%. Other income rose 35.29% to Rs 75.9 crore. PBIDT fell 3.58% to Rs 587.9 crore. Provision for interest rose 18.57% to Rs 8.3 crore. PBDT fell 3.83% to Rs 579.6 crore. Provision for depreciation rose 26.56% to Rs 99.1 crore. Profit before tax down 8.37% to Rs 480.50 crore. Share of profit/loss was 85.71% lower at Rs 0.2 crore. Provision for tax was expense of Rs 108 crore, compared to Rs 77.2 crore. Effective tax rate was 22.47% compared to 14.68%. Minority interest was nil in both the periods. Net profit attributable to owners of the company decreased 16.92% to Rs 372.70 crore. Promoters' stake was 46.09% as of 31 December 2024 ,compared to 46.09% as of 31 December 2023 .
The scrip is currently trading at Rs 3535
For year-to-date (YTD) results analysis
Net sales (including other operating income) of P I Industries has increased 4.49% to Rs 6190.7 crore. Sales of Chemicals segment has gone up 6.70% to Rs 6,061.90 crore (accounting for 97.90% of total sales). Sales of Pharma segment has gone down 46.55% to Rs 130.10 crore (accounting for 2.10% of total sales). Profit before interest, tax and other unallocable items (PBIT) has jumped 15.26% to Rs 1,709.80 crore. PBIT of Chemicals segment rose 21.72% to Rs 1,892.50 crore (accounting for 110.69% of total PBIT). PBIT of Pharma segment fell 155.88% to Rs -182.70 crore (accounting for -10.69% of total PBIT). PBIT margin of Chemicals segment rose from 27.37% to 31.22%. PBIT margin of Pharma segment fell from negative 29.33% to negative 140.43%. Overall PBIT margin rose from 25.04% to 27.61%. Operating profit margin has jumped from 26.55% to 27.84%, leading to 9.58% rise in operating profit to Rs 1,723.40 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 46.69% to 43.05%. Purchase of finished goods cost fell from 3.85% to 2.58%. Employee cost increased from 8.95% to 9.90%. Other expenses rose from 13.60% to 15.40%. Other income rose 80.65% to Rs 270.8 crore. PBIDT rose 15.76% to Rs 1994.2 crore. Provision for interest rose 31.41% to Rs 25.1 crore. PBDT rose 15.58% to Rs 1969.1 crore. Provision for depreciation rose 14.89% to Rs 262.3 crore. Profit before tax grew 15.69% to Rs 1,706.80 crore. Share of profit/loss was 62.96% lower at Rs 3 crore. Provision for tax was expense of Rs 380.1 crore, compared to Rs 171.4 crore. Effective tax rate was 22.23% compared to 11.55%. Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 1.35% to Rs 1,329.70 crore. Promoters' stake was 46.09% as of 31 December 2024 ,compared to 46.09% as of 31 December 2023 .The scrip is currently trading at Rs 3535
| P I Industries : Consolidated Results | |||||||||
| Particulars | 2412 (03) | 2312 (03) | Var.(%) | 2412 (09) | 2312 (09) | Var.(%) | 2403 (12) | 2303 (12) | Var.(%) |
| Net Sales | 1,900.80 | 1,897.50 | 0 | 6,190.70 | 5,924.80 | 4 | 7,665.80 | 6,492.00 | 18 |
| OPM (%) | 26.9 | 29.2 | 27.8 | 26.6 | 26.3 | 23.8 | |||
| OP | 512 | 553.6 | -8 | 1,723.40 | 1,572.80 | 10 | 2,014.70 | 1,542.10 | 31 |
| Other Inc. | 75.9 | 56.1 | 35 | 270.8 | 149.9 | 81 | 207.7 | 159 | 31 |
| PBIDT | 587.9 | 609.7 | -4 | 1,994.20 | 1,722.70 | 16 | 2,222.40 | 1,701.10 | 31 |
| Interest | 8.3 | 7 | 19 | 25.1 | 19.1 | 31 | 30 | 37.1 | -19 |
| PBDT | 579.6 | 602.7 | -4 | 1,969.10 | 1,703.60 | 16 | 2,192.40 | 1,664.00 | 32 |
| Depreciation | 99.1 | 78.3 | 27 | 262.3 | 228.3 | 15 | 308.2 | 226.5 | 36 |
| PBT | 480.5 | 524.4 | -8 | 1706.8 | 1475.3 | 16 | 1884.2 | 1437.5 | 31 |
| Share of Profit/(Loss) from Associates | 0.2 | 1.4 | -86 | 3 | 8.1 | -63 | 10.5 | 6.8 | 54 |
| PBT before EO | 480.7 | 525.8 | -9 | 1709.8 | 1483.4 | 15 | 1894.7 | 1444.3 | 31 |
| EO Income | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
| PBT after EO | 480.7 | 525.8 | -9 | 1709.8 | 1483.4 | 15 | 1894.7 | 1444.3 | 31 |
| Taxation | 108 | 77.2 | 40 | 380.1 | 171.4 | 122 | 213.2 | 214.8 | -1 |
| PAT | 372.7 | 448.6 | -17 | 1329.7 | 1312 | 1 | 1681.5 | 1229.5 | 37 |
| Minority Interest (MI) | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
| Net profit | 372.7 | 448.6 | -17 | 1329.7 | 1312 | 1 | 1681.5 | 1229.5 | 37 |
| EPS (Rs)* | # | # | # | # | 110.8 | 81.0 | |||
| Notes | |||||||||
| * EPS is on current equity of Rs 15.17 crore, Face value of Rs 1, Excluding extraordinary items. | |||||||||
| # EPS is not annualised | |||||||||
| bps : Basis points | |||||||||
| EO : Extraordinary items | |||||||||
| Figures in Rs crore | |||||||||
| Source: Capitaline Corporate Database | |||||||||
| P I Industries : Consolidated Segment Results | ||||||||||||
|
| % of (Total) | 2412 (03) | 2312 (03) | Var.(%) | % of (Total) | 2412 (09) | 2312 (09) | Var.(%) | % of (Total) | 2403 (12) | 2303 (12) | Var.(%) |
| Sales | ||||||||||||
| Agro Chemicals | 97 | 1,838.10 | 1,770.20 | 4 | 98 | 6,061.90 | 5,681.40 | 7 | 96 | 7,350.90 | 6,492.00 | 13 |
| Pharma | 3 | 63.7 | 127.3 | -50 | 2 | 130.1 | 243.4 | -47 | ||||
| Total Reported Sales | 100 | 1,901.80 | 1,897.50 | 0 | 100 | 6,192.00 | 5,924.80 | 5 | 100 | 7,665.80 | 6,492.00 | 18 |
| Less: Inter segment revenues | 1 | 0 | - | 1.3 | 0 | 0 | 0 | - | ||||
| Net Sales | 1,900.80 | 1,897.50 | 0 | 6,190.70 | 5,924.80 | 4 | 7,665.80 | 6,492.00 | 18 | |||
| PBIT | ||||||||||||
| Agro Chemicals | 112 | 536.6 | 544.1 | -1 | 111 | 1,892.50 | 1,554.80 | 22 | 106 | 2,005.10 | 1,326.80 | 51 |
| Pharma | -12 | -55.9 | -18.3 | -205 | -11 | -182.7 | -71.4 | -156 | -6 | -110.4 | -11.2 | -886 |
| Total PBIT | 100 | 480.7 | 525.8 | -9 | 100 | 1,709.80 | 1,483.40 | 15 | 100 | 1,894.70 | 1,315.60 | 44 |
| Less : Interest | 0 | 0 | - | 0 | 0 | - | 0 | 37.1 | - | |||
| Add: Other un-allcoable | 0 | 0 | - | 0 | 0 | - | 0 | 165.8 | - | |||
| PBT | 480.7 | 525.8 | -9 | 1,709.80 | 1,483.40 | 15 | 1,894.70 | 1,444.30 | 31 | |||
